2-Deoxyglucose-Modified Folate Derivative: Self-Assembling Nanoparticle Able to Load Cisplatin

Area of Science:

• Nanotechnology
• Drug Delivery
• Biochemistry

Background:

• Folic acid is used in nano-drug delivery for targeting.
• Poor water solubility of folic acid limits its drug loading capacity.

Purpose of the Study:

• To synthesize and characterize a new folate derivative (FA-2-DG).
• To evaluate FA-2-DG self-assembly and cisplatin loading capabilities.

Main Methods:

• Synthesis of FA-2-DG from folic acid and 2-Deoxyglucose.
• Determination of critical micelle concentration (CMC).
• Fourier transform infrared spectroscopy (FTIR) for self-assembly analysis.
• Stability studies in aqueous and protein dispersions.
• Coordination bond formation for cisplatin loading.

Main Results:

• FA-2-DG exhibits self-assembly characteristics with a CMC of 7.94 × 10⁻⁶ mol L⁻¹.
• Hydrogen bonding drives FA-2-DG self-assembly.
• FA-2-DG particles demonstrate stability in water and bovine serum albumin dispersions.
• Cisplatin loading via coordination bonds achieved maximal efficiency at a 2:1 FA-2-DG to cisplatin molar ratio.

Conclusions:

• FA-2-DG is a promising derivative for nano-drug delivery systems.
• The derivative overcomes folic acid's solubility limitations for drug loading.
• FA-2-DG effectively self-assembles and loads cisplatin for potential antineoplastic drug applications.